发明名称 |
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN, ACID LABILE SUBUNIT (IGFALS) AND INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |
摘要 |
The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting the insulin-like growth factor binding protein, acid labile subunit (IGFALS) gene or the insulin-like growth factor 1 (IGF-1) gene, methods of using such double stranded RNAi agents to inhibit expression of an IGFALS gene or an IGF-1 gene, and methods of treating subjects having an IGF system-associated disorder. |
申请公布号 |
WO2017011286(A1) |
申请公布日期 |
2017.01.19 |
申请号 |
WO2016US41440 |
申请日期 |
2016.07.08 |
申请人 |
ALNYLAM PHARMACEUTICALS, INC. |
发明人 |
BUTLER, James;FITZGERALD, Kevin;HINKLE, Gregory;BETTENCOURT, Brian;XU, Huilei |
分类号 |
C12N15/113;A61K31/712 |
主分类号 |
C12N15/113 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|